questionText: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the (a) development and (b) approval of (i) second- and third-line tyrosine kinase inhibitors and (ii) other targeted therapy options for patients with ROS1-positive cancer; and whether his Department has had recent discussions with (A) the National Institute for Health and Care Excellence and (B) pharmaceutical companies on encouraging clinical trial funding in this area.
answerText: The National Institute for Health and Care Excellence (NICE) is the independent body that develops recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS based on an assessment of clinical a...
heading: Cancer: Medical Treatments